Add to ORKGre i2, K Gastric cancer is the second leading cause of cancer death worldwide with approximately 989,600 new cases and platinum regimen is a standard first-line chemother-apy in HER2-negative metastatic gastric cancer (mGC) Takahashi et al. BMC Research Notes 2014, 7:27
Esophageal and stomach cancers are two of the most common malignancies worldwide. In 2012, these two...
Despite the decline in the global incidence, gastric cancer (GC) remains the second leading cause of...
Gastric cancer remains a significant health problem despite combination chemotherapy has reported a ...
Gastric cancer is the fourth most common cancer in men and the fifth most common cancer in wom-en wo...
In spite of significant advances in experimental research, diagnosis and treatment, gastric cancer (...
Full list of author information is available at the end of the articlelung cancer, and is a major he...
Full list of author information is available at the end of the articleGastric cancer is one of the m...
Although the incidence of gastric cancer is declining, it remains the second leading cause of cancer...
Background: Docetaxel plus cisplatin (DP) is a combination chemotherapy regimen that is active again...
Abstract: Background: The assessment of human epidermal growth factor receptor 2 (HER2) gene amplifi...
esophageal cancer cases and 989,600 new gastric cancer cases diagnosed in 2008 worldwide. However, i...
Despite its declining incidence, gastric cancer remains a worldwide health problem that accounts for...
Purpose: At present, a human epidermal growth factor receptor 2 (HER2)-based concept of tumor biolog...
Despite its declining incidence, gastric cancer remains a worldwide health problem that accounts for...
Gastric cancer ranks fourth in incidence and second in mortality among all cancers worldwide. Despit...
Esophageal and stomach cancers are two of the most common malignancies worldwide. In 2012, these two...
Despite the decline in the global incidence, gastric cancer (GC) remains the second leading cause of...
Gastric cancer remains a significant health problem despite combination chemotherapy has reported a ...
Gastric cancer is the fourth most common cancer in men and the fifth most common cancer in wom-en wo...
In spite of significant advances in experimental research, diagnosis and treatment, gastric cancer (...
Full list of author information is available at the end of the articlelung cancer, and is a major he...
Full list of author information is available at the end of the articleGastric cancer is one of the m...
Although the incidence of gastric cancer is declining, it remains the second leading cause of cancer...
Background: Docetaxel plus cisplatin (DP) is a combination chemotherapy regimen that is active again...
Abstract: Background: The assessment of human epidermal growth factor receptor 2 (HER2) gene amplifi...
esophageal cancer cases and 989,600 new gastric cancer cases diagnosed in 2008 worldwide. However, i...
Despite its declining incidence, gastric cancer remains a worldwide health problem that accounts for...
Purpose: At present, a human epidermal growth factor receptor 2 (HER2)-based concept of tumor biolog...
Despite its declining incidence, gastric cancer remains a worldwide health problem that accounts for...
Gastric cancer ranks fourth in incidence and second in mortality among all cancers worldwide. Despit...
Esophageal and stomach cancers are two of the most common malignancies worldwide. In 2012, these two...
Despite the decline in the global incidence, gastric cancer (GC) remains the second leading cause of...
Gastric cancer remains a significant health problem despite combination chemotherapy has reported a ...